//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...









Loading...
@sophiedautricourt.bsky.social @hcl-recherche.bsky.social @hospicescivilslyon.bsky.social May interest @fredericblanc.bsky.social @a2mcl.bsky.social @michaelokun.bsky.social ! ☝️
2mo
⚠️New review straight out of the oven! "Spatial navigation in preclinical Alzheimer's disease: A review" arxiv.org/abs/2603.23082 We focus on spatial navigation as a sensitive cognitive marker in preclinical AD, compiling evidence from cognitively unimpaired individuals with positive AD biomarkers.
2mo
Antoine Garnier-Crussard
ICYMI: New online! The potential of low-field MRI for global dementia care
2mo
Spatial navigation in preclinical Alzheimer's disease: A review New review from @antoinegc.bsky.social and @antoinecoutrot.bsky.social labs, on which I am a co-author, and first author is the amazing Syrine Salouhou arxiv.org/abs/2603.23082
2mo
Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
How should we interpret white matter hyperintensities (WMHs) in Alzheimer’s disease in the era of anti-amyloid therapies ? This perspective article examines how WMHs may influence both: 1️⃣ the expected benefit of anti-amyloid therapies in patients with WMHs 2️⃣ and the potential risk of ARIA 🧵2/
2mo
🧵3/ 👉We argue that WMH should no longer be viewed as a single nonspecific imaging finding, but as heterogeneous markers 👉 Qualitative WMH patterns, advanced MRI phenotyping and multimodal biomarker integration could help better interpret WMH 👉 We need more definitive trial and registry evidence
28d
🚨 Paper alert 👉 White matter hyperintensities in Alzheimer's disease in the era of anti-amyloid therapies 🔓 Link to the (open access) paper = lnkd.in/dGx6hh9g 🧵👇 (1/)
Nature Reviews Neurology
🚨Paper Alert Happy to share this paper led by A. Flaus & C. Gayor on dual isotope SPECT in dementia with Lewy bodies : one exam, two informations !! With dopamine transporter and perfusion imaging in a single session (CZT SPECT) 🔓 Open access paper shorturl.at/RhvtF
28d
🧵4/4 🙏 Grateful to this international group of co-authors for the collaboration, @dadarmahsa.bsky.social @nicolascabe.eurosky.social, A Charidimou, G Boulouis, F Cotton, A Brickman, G Chételat published in @alzdemjournals.bsky.social @neuropreneurs.bsky.social @hclark.bsky.social
Antoine Coutrot
28d
2mo
28d
Antoine Garnier-Crussard
Antoine Garnier-Crussard
Antoine Garnier-Crussard
Antoine Garnier-Crussard
Hugo Spiers
Antoine Garnier-Crussard
Antoine Garnier-Crussard